Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash $ 201,092 $ 487,953
Accounts receivable - net of allowance of $344,412 as of March 31, 2020 and December 31, 2019 606,215 799,246
Prepaid expenses and other assets 378,155 11,160
Total current assets 1,185,462 1,298,359
Fixed assets 102,941 105,199
Goodwill 8,366,467 8,366,467
Intangible assets 195,733 205,219
Other assets 17,561
Total assets 9,850,603 9,992,805
Current liabilities:    
Accounts payable and accrued liabilities 2,316,405 2,010,556
Contract liabilities 1,390,637 1,056,637
Total current liabilities 3,707,042 3,067,193
Commitments and contingencies
Stockholders' equity:    
Series A Convertible Preferred stock, $0.001 par value; 900,000 shares authorized; 511,067 and 578,567 shares issued and outstanding, respectively 511 579
Common stock, $0.001 par value; 45,000,000 shares authorized; 7,634,561 and 7,390,261 shares issued and outstanding, respectively 7,636 7,391
Additional paid-in capital 20,079,538 19,712,115
Accumulated deficit (13,944,124) (12,794,473)
Total stockholders' equity 6,143,561 6,925,612
Total liabilities and stockholders’ equity $ 9,850,603 $ 9,992,805